1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Autoimmune Drug Focus DECEMBER 2015

Autoimmune Drug Focus DECEMBER 2015

  • December 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Takeda Looks To Capitalise On Coeliac Disease Market
Industry Brief - Oramed/Hefei Sign Chinese Licensing Deals For Oral Insulin Capsule
Industry Brief - Novo Nordisk Seeks EU Approval For Faster-Acting Insulin Aspart In Type I/II Diabetes
Industry Trend Analysis - BIL Discontinuation Will Not Alter Lilly's Diabetes Market Outlook
Industry Brief - Novo Nordisk Seeks FDA Approval For Faster-Acting Insulin Aspart In Type I/II Diabetes
Industry Brief - FDA Approves Basaglar For Diabetes
Industry Trend Analysis - Perrigo Will See Steady Entocort Revenues But Potential Threats Exist
Industry Brief - TxCell Reacquires Full Rights To Ovasave
Industry Trend Analysis - Maximising Stelara Indications Will Offset Expected Declining Remicade Revenue
Industry Brief - Filgotinib Meets Primary Endpoint In Phase II CD Study
Industry Trend Analysis - Successful Ofev And Esbriet Trial Results Will Lock Down IPF Market
Industry Trend Analysis - South Korea Agreement Positions Neovacs To Capitalise On Key Lupus Market
Industry Trend Analysis - Japanese Copaxone Sales Will Not Forestall US Generic Losses
Industry Trend Analysis - US Filing Underlines Amgen's Biosimilar Market Leader Ambitions
Industry Brief - Eisai/Toyama Clear All-Case Surveillance Condition For Iguratimod Approval In RA
Industry Brief - Samsung Bioepis' Renflexis Biosimilar Approved In South Korea
Industry Brief - Health Canada Approves Expanded Indication For Humira
Industry Brief - Amgen Submits Biosimilar Adalimumab MAA To EMA
Industry Brief - EMA Accepts Sandoz' Etanercept Submission
Industry Brief - GSK Receives Positive Results From Sirukumab Phase III Programme In RA
Industry Brief - BMS/Ono Initiate Orencia Phase IIIb RA Study
Industry Brief - Brickell Secures Global Rights To Inhibitors For Psoriasis And Other Autoimmune Diseases
Industry Brief - Cipher's Beteflam Approved In Canada For Plaque Psoriasis
Industry Brief - GSK Initiates Sirukumab Phase III Study In GCA
Industry Brief - Galapagos/Gilead To Co-Develop Filgotinib For Inflammatory Diseases
Industry Brief - Remicade Approved In Japan For Kawasaki Disease
Industry Brief - GSK Completes Divestment Of Ofatumumab Rights For Autoimmune Indications To Novartis
Industry Brief - Autoimmune Conferences - March 2016

Table Of Contents

Autoimmune Drug Focus DECEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.